中國人民保險集團(01339.HK):社保基金會擬減持不超2%股份
格隆匯7月23日丨中國人民保險集團(01339.HK)發佈公吿,近日,公司第二大股東全國社會保障基金理事會來函通知,計劃減持公司部分無限售條件A股股份。因全國社會保障基金資產配置和投資業務需要,社保基金會計劃通過集中競價或大宗交易方式,自本公吿之日起15個交易日後的六個月內減持公司無限售條件A股不超過884,479,811股,即不超過公司當前已發行股份總數的2%,減持價格視二級市場價格確定,股份減持交易將由社保基金會所委託的減持管理人負責實施。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.